Healthcare provider profile · identity verified

Frank S Amato, ARNP

Nurse Practitioner · ST PETERSBURG, FL · NPI 1417940347

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	530	67
Levothyroxine Sodium	Levothyroxine Sodium	333	40
Potassium Chloride	Potassium Chloride	331	44
Furosemide	Furosemide	330	47
Amlodipine Besylate	Amlodipine Besylate	276	49
Eliquis	Apixaban	270	38
Sertraline Hcl	Sertraline Hcl	268	36
Gabapentin	Gabapentin	233	34
Lisinopril	Lisinopril	223	33
Trazodone Hcl	Trazodone Hcl	216	29
Tamsulosin Hcl	Tamsulosin Hcl	207	32
Losartan Potassium	Losartan Potassium	197	25
Omeprazole	Omeprazole	197	26
Metoprolol Tartrate	Metoprolol Tartrate	187	30
Clopidogrel	Clopidogrel Bisulfate	177	22
Donepezil Hcl	Donepezil Hcl	171	21
Pantoprazole Sodium	Pantoprazole Sodium	148	30
Famotidine	Famotidine	132	21
Carvedilol	Carvedilol	131	15
Metoprolol Succinate	Metoprolol Succinate	131	17
Metformin Hcl	Metformin Hcl	126	19
Loperamide	Loperamide Hcl	119	39
Rosuvastatin Calcium	Rosuvastatin Calcium	102	14
Diclofenac Sodium	Diclofenac Sodium	93	14
Escitalopram Oxalate	Escitalopram Oxalate	93	12
Hydralazine Hcl	Hydralazine Hcl	87	13
Alcohol Prep Pads	Alcohol Antiseptic Pads	83	12
Spironolactone	Spironolactone	82	suppressed
Mirtazapine	Mirtazapine	80	17
Nifedipine Er	Nifedipine	79	11
Ibuprofen	Ibuprofen	78	18
Atenolol	Atenolol	74	suppressed
Celecoxib	Celecoxib	67	11
Memantine Hcl	Memantine Hcl	63	15
Levetiracetam	Levetiracetam	61	suppressed
Meloxicam	Meloxicam	59	14
Carbidopa-Levodopa	Carbidopa/Levodopa	58	suppressed
Tizanidine Hcl	Tizanidine Hcl	58	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	57	12
Fluticasone Propionate	Fluticasone Propionate	57	14
Finasteride	Finasteride	56	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	56	suppressed
Bumetanide	Bumetanide	53	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	53	suppressed
Duloxetine Hcl	Duloxetine Hcl	49	suppressed
Simvastatin	Simvastatin	48	suppressed
Baclofen	Baclofen	47	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	47	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	46	suppressed
Xarelto	Rivaroxaban	46	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	43	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	43	suppressed
Divalproex Sodium	Divalproex Sodium	42	suppressed
Latanoprost	Latanoprost	42	suppressed
Amiodarone Hcl	Amiodarone Hcl	41	suppressed
Ondansetron Hcl	Ondansetron Hcl	41	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	40	23
Glipizide	Glipizide	39	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	38	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	37	suppressed
Midodrine Hcl	Midodrine Hcl	37	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	37	suppressed
Paroxetine Hcl	Paroxetine Hcl	35	suppressed
Pravastatin Sodium	Pravastatin Sodium	34	suppressed
Diltiazem Hcl	Diltiazem Hcl	33	suppressed
Allopurinol	Allopurinol	32	suppressed
Methenamine Hippurate	Methenamine Hippurate	32	suppressed
Trulicity	Dulaglutide	32	suppressed
Ammonium Lactate	Ammonium Lactate	31	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	30	22
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	30	suppressed
Primidone	Primidone	30	suppressed
Buspirone Hcl	Buspirone Hcl	29	suppressed
Ultra-Fine Original Pen Needle	Pen Needle, Diabetic	29	suppressed
Creon	Lipase/Protease/Amylase	28	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	28	suppressed
Myrbetriq	Mirabegron	28	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	28	suppressed
Bupropion Hcl	Bupropion Hcl	27	suppressed
Cilostazol	Cilostazol	27	suppressed
Jardiance	Empagliflozin	27	suppressed
Megestrol Acetate	Megestrol Acetate	27	suppressed
Topiramate	Topiramate	27	suppressed
Januvia	Sitagliptin Phosphate	26	suppressed
Metformin Hcl Er	Metformin Hcl	26	suppressed
Ventolin Hfa	Albuterol Sulfate	26	suppressed
Fenofibrate	Fenofibrate	25	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	25	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	25	suppressed
Labetalol Hcl	Labetalol Hcl	24	suppressed
Methimazole	Methimazole	24	suppressed
Calcitriol	Calcitriol	23	suppressed
Lovastatin	Lovastatin	23	suppressed
Nystatin	Nystatin	23	suppressed
Citalopram Hbr	Citalopram Hydrobromide	22	suppressed
Ketoconazole	Ketoconazole	22	suppressed
Cholestyramine	Cholestyramine (With Sugar)	21	suppressed
Montelukast Sodium	Montelukast Sodium	21	suppressed
Ondansetron Odt	Ondansetron	21	suppressed
Propranolol Hcl	Propranolol Hcl	21	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	19	suppressed
Flecainide Acetate	Flecainide Acetate	19	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Symbicort	Budesonide/Formoterol Fumarate	19	suppressed
Azithromycin	Azithromycin	18	17
Isosorbide Dinitrate	Isosorbide Dinitrate	18	suppressed
Methocarbamol	Methocarbamol	18	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	17	suppressed
Methylprednisolone	Methylprednisolone	17	16
Nitrofurantoin	Nitrofurantoin Macrocrystal	17	suppressed
Risperidone	Risperidone	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Cephalexin	Cephalexin	16	13
Fondaparinux Sodium	Fondaparinux Sodium	16	suppressed
Hydrocortisone	Hydrocortisone	16	suppressed
Aripiprazole	Aripiprazole	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Farxiga	Dapagliflozin Propanediol	15	suppressed
Naproxen	Naproxen	15	suppressed
Bupropion Xl	Bupropion Hcl	14	suppressed
Divalproex Sodium Er	Divalproex Sodium	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	14	suppressed
Linzess	Linaclotide	14	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	14	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	13	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	13	suppressed
Entresto	Sacubitril/Valsartan	13	suppressed
Glimepiride	Glimepiride	13	suppressed
Lumigan	Bimatoprost	13	suppressed
Novolog Flexpen	Insulin Aspart	13	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	13	suppressed
Prednisone	Prednisone	13	suppressed
Sotalol	Sotalol Hcl	13	suppressed
Spiriva Respimat	Tiotropium Bromide	13	suppressed
Sulfasalazine	Sulfasalazine	13	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	13	suppressed
Breyna	Budesonide/Formoterol Fumarate	12	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	12	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	12	suppressed
Incruse Ellipta	Umeclidinium Bromide	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Alphagan P	Brimonidine Tartrate	11	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Cholestyramine Light	Cholestyramine	11	suppressed
Nystop	Nystatin	11	suppressed
Olanzapine	Olanzapine	11	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	11	suppressed
Ozempic	Semaglutide	11	suppressed
Travoprost	Travoprost	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error